HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideya Mizuno Selected Research

Neoplasms (Cancer)

6/2006Involvement of the paxillin pathway in JB6 Cl41 cell transformation.
7/2005Phosphorylation of histone H3 at serine 10 is indispensable for neoplastic cell transformation.
6/2004A novel role for mixed-lineage kinase-like mitogen-activated protein triple kinase alpha in neoplastic cell transformation and tumor development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideya Mizuno Research Topics

Disease

5Parkinson Disease (Parkinson's Disease)
12/2010 - 09/2007
3Neurodegenerative Diseases (Neurodegenerative Disease)
12/2010 - 03/2008
3Neoplasms (Cancer)
06/2006 - 06/2004
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2017 - 01/2014
2Lewy Body Disease (Lewy Body Dementia)
09/2008 - 03/2008
2Dementia (Dementias)
06/2008 - 09/2007
2Carcinogenesis
03/2006 - 06/2004
2Neoplastic Cell Transformation
07/2005 - 06/2004
1Muscular Diseases (Myopathy)
03/2011
1Muscular Dystrophies (Muscular Dystrophy)
03/2011
1Animal Muscular Dystrophy
03/2011
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
03/2011
1Synucleinopathies
12/2010
1Psychotic Disorders (Schizoaffective Disorder)
09/2008
1Bipolar Disorder (Manic Depressive Psychosis)
09/2008
1Schizophrenia (Dementia Praecox)
09/2008
1Cognitive Dysfunction
03/2008
1Alzheimer Disease (Alzheimer's Disease)
09/2007
1Nervous System Diseases (Neurological Disorders)
09/2007
1Stroke (Strokes)
09/2007
1Fibrosarcoma
06/2004
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
04/2002

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
03/2011 - 06/2004
4alpha-SynucleinIBA
09/2008 - 03/2008
3Biomarkers (Surrogate Marker)IBA
03/2011 - 09/2007
2Phosphotransferases (Kinase)IBA
06/2006 - 06/2004
1bergamottinIBA
01/2017
1Therapeutic UsesIBA
01/2014
1MicroRNAs (MicroRNA)IBA
03/2011
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2011
1DystrophinIBA
03/2011
1SynucleinsIBA
12/2010
1DNA (Deoxyribonucleic Acid)IBA
09/2008
1Messenger RNA (mRNA)IBA
09/2008
1Amyloid beta-PeptidesIBA
09/2008
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2008
1Anticholesteremic AgentsIBA
06/2008
1CholesterolIBA
06/2008
1EnzymesIBA
09/2007
1ImmunosorbentsIBA
09/2007
1PaxillinIBA
06/2006
1Tyrosine (L-Tyrosine)FDA Link
06/2006
1Mitogen-Activated Protein KinasesIBA
06/2006
1theaflavinIBA
03/2006
1TeaIBA
03/2006
1Epidermal Growth Factor (EGF)IBA
07/2005
1Serine (L-Serine)FDA Link
07/2005
1Histones (Histone)IBA
07/2005
1MLK-like mitogen-activated protein triple kinaseIBA
06/2004
1MitogensIBA
06/2004
1Small Interfering RNA (siRNA)IBA
06/2004
1Ginkgo biloba extract (Rokan)IBA
04/2002

Therapy/Procedure

1Therapeutics
12/2010
1Injections
06/2004